Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Gains from Investment Securities (2016 - 2025)

Sonoma Pharmaceuticals has reported Gains from Investment Securities over the past 16 years, most recently at $2918.0 for Q4 2025.

  • For Q4 2025, Gains from Investment Securities rose 1067.2% year-over-year to $2918.0; the TTM value through Dec 2025 reached $2918.0, up 1067.2%, while the annual FY2025 figure was $73081.0, 41.42% up from the prior year.
  • Gains from Investment Securities for Q4 2025 was $2918.0 at Sonoma Pharmaceuticals, up from $229.0 in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $992999.0 in Q2 2024 and troughed at $229.0 in Q3 2025.
  • A 5-year average of $263270.8 and a median of $122040.5 in 2021 define the central range for Gains from Investment Securities.
  • Biggest five-year swings in Gains from Investment Securities: soared 11495.94% in 2022 and later plummeted 99.95% in 2024.
  • Year by year, Gains from Investment Securities stood at $3500.0 in 2021, then skyrocketed by 16344.17% to $575546.0 in 2022, then decreased by 13.13% to $500000.0 in 2023, then plummeted by 99.95% to $250.0 in 2024, then surged by 1067.2% to $2918.0 in 2025.
  • Business Quant data shows Gains from Investment Securities for SNOA at $2918.0 in Q4 2025, $229.0 in Q3 2025, and $9000.0 in Q2 2025.